PREVENTION OF CARDIOVASCULAR DISEASE IN ARID REGIONS: THE ROLE OF CLIMATIC AND GEOGRAPHIC DETERMINANTS

Main Article Content

Аннотация:

Cardiovascular disease (CVD) remains one of the leading causes of morbidity and mortality across the globe. While well-established risk factors such as hypertension, obesity, and sedentary lifestyles are frequently studied, the contribution of environmental determinants; especially climate and geography has received comparatively less attention. Arid regions, characterized by persistent high temperatures, scarce vegetation, limited water resources, and low humidity, create unique physiological and lifestyle stressors that may accelerate cardiovascular risk. In these areas, dehydration, thermal strain, salt retention due to restricted water intake, and reduced access to healthcare services collectively intensify the burden of CBD. This study investigates the influence of arid climate and geographic determinants on cardiovascular health outcomes, with a focus on variations across age and sex. By identifying patterns of vulnerability such as the higher susceptibility of older adults and men. This research emphasizes the need for tailored preventive strategies adapted to environmental realities.

Article Details

Как цитировать:

Pulatova , K., Miniyarova , A. ., Anbreen , F., Rofeev , M. ., & Nazarova , Z. . (2025). PREVENTION OF CARDIOVASCULAR DISEASE IN ARID REGIONS: THE ROLE OF CLIMATIC AND GEOGRAPHIC DETERMINANTS. Евразийский журнал медицинских и естественных наук, 5(11), 206–209. извлечено от https://in-academy.uz/index.php/EJMNS/article/view/66341

Библиографические ссылки:

Abdulloyeva , M., Pulatova , K., & Mirzaev , R. (2023). ORTIQCHA VAZN VA ARTERIAL GIPERTONIYA BILAN OG'RIGAN YOSHLARDA YUZAGA KELADIGAN JINSIY ZAIFLIK. Eurasian Journal of Medical and Natural Sciences , 3 (4 Part 2), 91–94. retrieved from https://in-academy.uz/index.php/EJMNS/article/view/13515

Bakhtiyarovich A. A., Samvelovna P. K. Peculiarities of the Influence of Metabolic Syndrome on the Course of Coronary Heart Disease //American Journal of Pediatric Medicine and Health Sciences (2993-2149). – 2023. – Т. 1. – №. 8. – С. 396-400.

Dilshodovna , A. M., Odylovna , K. F., & Samveilovna , P. K. (2022). Peculiarities of Psychological Disorders in Patients with Acute Coronary Syndrome. INTERNATIONAL JOURNAL OF HEALTH SYSTEMS AND MEDICAL SCIENCES , 1 (6), 203–207. Retrieved from http://inter-publishing.com/index.php/IJHSMS/article/view/695

Kristina Samvelovna Pulatova , Timur Mukhitdinovich Pulatov , Mukhammad Olimovich Esankulov THE SPECIFIC FEATURES OF ARTERIAL HYPERTENSION IN OWERWEIGHT PATIENTS WITH PSORIASIS // Academic research in educational sciences. 2021. No. 2. URL: https://cyberleninka.ru/article/n/the-specific-features-of-arterial-hypertension-in-owerweight-patients-with-psoriasis (access date: 05/13/2023).

Nasyrova Zarina Akbarovna , Abdulloeva Maftuna Dilshodovna , Usarov Shohruh Abduvahob Ugli STRATIFICATION OF RISK FACTORS IN CORONARY HEART DISEASE // JCRR. 2021. No. 3. URL: https://cyberleninka.ru/article/n/stratifikatsiya-faktorov-riska-pri-ishemicheskoy-bolezni-serdtsa (date of access: 05/13/2023).

Pulatova K. Analysis of Ecg and Echo Results in Hypertensive Patients Depending on Bmi Degrees //International Journal of Health Systems and Medical Sciences. – 2023.https://cajmns.centralasianstudies.org/index.php/CAJMNS/article/view/1193

Пулатова К. ИЗМЕНЕНИЯ ГЕМОДИНАМИЧЕСКИХ ПОКАЗАТЕЛЕЙ БОЛЬНЫХ С ИЗБЫТОЧНЫМ ВЕСОМ ПРИ ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦА //Евразийский журнал медицинских и естественных наук. – 2024. – Т. 4. – №. 1. – С. 68-71.

Mirzayev M., Dhanwani R., Shivansh S. CHRONIC HEART FAILURE: NEW TREATMENT STRATEGIES //International Journal of Artificial Intelligence. – 2025. – Т. 1. – №. 5. – С. 433-439.

Li S, Zhang Y, Xu RX, et al. Novel insulin resistance index and cardiovascular outcomes in patients with acute coronary syndrome. Diab Vasc Dis Res. 2023;19(2):14791641221076898.

Martínez-Sánchez C, González-Pacheco H, et al. Impact of metabolic syndrome on outcomes after coronary stenting. JACC Cardiovasc Interv. 2023;15(6):642-654.

Neeland IJ, Ross R, Després JP, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2023;7(9):715-725.

Pavlou DI, Paschou SA, et al. Insulin resistance in cardiovascular disease: Pathophysiology and therapeutic implications. Postgrad Med. 2024;136(1):20-28.